Weinian Shou Selected Research

tacrolimus binding protein 4 (FKBP52)

9/2010	Fkbp52 regulates androgen receptor transactivation activity and male urethra morphogenesis.
7/2010	Susceptibility to diet-induced hepatic steatosis and glucocorticoid resistance in FK506-binding protein 52-deficient mice.
10/2007	The immunophilin ligands cyclosporin A and FK506 suppress prostate cancer cell growth by androgen receptor-dependent and -independent mechanisms.
2/2007	Essential role for Co-chaperone Fkbp52 but not Fkbp51 in androgen receptor-mediated signaling and physiology.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Weinian Shou Research Topics

Disease

7	Neoplasms (Cancer) 01/2021 - 12/2007
3	Fibrosis (Cirrhosis) 12/2019 - 01/2016
2	Myocardial Infarction 01/2019 - 01/2017
2	Hypersensitivity (Allergy) 11/2018 - 08/2009
2	Carcinogenesis 11/2018 - 12/2015
2	Inflammation (Inflammations) 10/2018 - 02/2012
2	Hypertrophy 01/2018 - 01/2016
2	Cardiomegaly (Heart Hypertrophy) 01/2018 - 12/2011
2	Hyperinsulinism (Hyperinsulinemia) 01/2016 - 07/2010
2	Cardiotoxicity 07/2014 - 01/2009
2	Obesity 12/2011 - 07/2010
2	Glioblastoma (Glioblastoma Multiforme) 04/2011 - 03/2011
2	Ataxia Telangiectasia (Louis Bar Syndrome) 03/2011 - 05/2007
2	Hypospadias 09/2010 - 02/2007
1	Neurodevelopmental Disorders 01/2021
1	Heart Diseases (Heart Disease) 11/2019
1	AIDS-Related Complex (ARC) 01/2019
1	Infarction (Infarctions) 01/2019
1	Atrial Fibrillation 01/2019
1	Atrophy 10/2018
1	Homozygous Familial Hypercholesterolemia 10/2018
1	Heart Failure 10/2018
1	Hypoxia (Hypoxemia) 01/2017
1	Edema (Dropsy) 10/2016
1	Mental Disorders (Mental Disorder) 08/2016
1	Hypertension (High Blood Pressure) 01/2016
1	Lymphatic Abnormalities 12/2015
1	Hepatocellular Carcinoma (Hepatoma) 12/2015
1	Long QT Syndrome 10/2012
1	Cardiac Arrhythmias (Arrythmia) 08/2012
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 12/2011
1	Cardiomyopathies (Cardiomyopathy) 12/2011
1	Ischemia 10/2011

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2019 - 05/2007
4	Tacrolimus Binding Proteins (FKBP)IBA 01/2019 - 07/2010
4	tacrolimus binding protein 4 (FKBP52)IBA 09/2010 - 02/2007
3	Biological ProductsIBA 01/2021 - 12/2007
3	Tacrolimus Binding Protein 1A (FKBP12)IBA 01/2019 - 12/2015
3	tissue-factor-pathway inhibitor 2 (PP5)IBA 11/2018 - 10/2007
2	protein phosphatase 5IBA 11/2018 - 05/2007
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 10/2018 - 08/2016
2	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2014 - 01/2009
2	Sodium Channels (Sodium Channel)IBA 10/2012 - 08/2012
2	Androgen Receptors (Androgen Receptor)IBA 09/2010 - 10/2007
2	Free RadicalsIBA 01/2009 - 12/2007
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2021
1	RNA Precursors (Precursor, mRNA)IBA 01/2021
1	Heterogeneous-Nuclear Ribonucleoprotein KIBA 01/2021
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 12/2019
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 12/2019
1	Protein Kinases (Protein Kinase)IBA 11/2019
1	Mechanistic Target of Rapamycin Complex 1IBA 11/2019
1	Sirolimus (Rapamycin)FDA Link 11/2019
1	Multiprotein ComplexesIBA 11/2019
1	Serotonin ReceptorsIBA 01/2019
1	SodiumIBA 01/2019
1	Serotonin (5 Hydroxytryptamine)IBA 01/2019
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 11/2018
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 11/2018
1	TensinsIBA 11/2018
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 11/2018
1	SteroidsIBA 10/2018
1	GlucocorticoidsIBA 10/2018
1	Ezetimibe (Zetia)FDA Link 10/2018
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2018
1	Biomarkers (Surrogate Marker)IBA 10/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2018
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2018
1	Glycogen Synthase KinasesIBA 01/2018
1	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2018
1	CalcineurinIBA 01/2018
1	Angiotensin IIIBA 01/2018
1	tacrolimus binding protein 1BIBA 01/2018
1	Long Noncoding RNAIBA 01/2017
1	ParaquatIBA 01/2017
1	Carrier Proteins (Binding Protein)IBA 08/2016
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2016
1	FructoseIBA 01/2016
1	fibroblast growth factor 21IBA 01/2016
1	CateninsIBA 12/2015
1	Transcription Factor 7-Like 2 ProteinIBA 12/2015
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 12/2015
1	Pharmaceutical PreparationsIBA 07/2014
1	AnthracyclinesIBA 07/2014
1	Lidocaine (Xylocaine)FDA LinkGeneric 10/2012
1	metaperiodate (periodate)IBA 02/2012
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 12/2011
1	Transforming Growth Factor beta (TGF-beta)IBA 12/2011
1	CalciumIBA 12/2011
1	gamma Catenin (Plakoglobin)IBA 12/2011
1	Indicators and Reagents (Reagents)IBA 10/2011
1	statticIBA 10/2011
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 10/2011
1	plerixafor FDA Link 10/2011
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2011
1	Transcription Factors (Transcription Factor)IBA 04/2011

Therapy/Procedure

2	Therapeutics 10/2018 - 03/2011
1	Analgesia 01/2019
1	Parenteral Infusions 01/2016
1	Ligation 12/2015